Retraction

Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.3389/fonc.2021.839904
Additional Notes:

see also: https://blog.frontiersin.org/2021/12/13/investigation-of-potentially-falsified-research/

Citations (31)

31
Total Citations
15
Post-Retraction
(48.4%)
16
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
3 Within 30 days
7 Within 1 year
3 After 2+ years
1169 Days since retraction (latest)
Potential biological roles of exosomal non‐coding <scp>RNAs</scp> in breast cancer
Li Xiang, Junyi Gong, Xiang Ni et al. (6 authors)
The FASEB Journal Open Access
Published: Mar 2025
1 citation
1169 days after retraction
‘Investigation of miRNAs That Affect the PI3K/AKT/mTOR Signaling Pathway in Endometrial Cancer’
Hasan Öz, Necmiye Canacankatan, Şerife Efsun Antmen et al. (5 authors)
Cell Biochemistry and Biophysics
Published: Feb 2025
1149 days after retraction
The role of ncRNAs and exosomes in the development and progression of endometrial cancer
Julia Niebora, Sławomir Woźniak, Dominika Domagała et al. (13 authors)
Frontiers in Oncology Open Access
Published: Aug 2024
3 citations
956 days after retraction
MicroRNA-221-3p Targets THBS1 to Promote Wound Healing in Diabetes
Keyan Hu, Xueying Liu, Hongfeng Chang et al. (10 authors)
Diabetes Metabolic Syndrome and Obesity Open Access
Published: Sep 2023
3 citations
610 days after retraction
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer
P. Cabello, Sandra Torres‐Ruiz, Anna Adam‐Artigues et al. (16 authors)
Cancers Open Access
Published: Apr 2023
15 citations
460 days after retraction
Exosomal miRNAs as novel avenues for breast cancer treatment
Tejveer Singh, Mahesh C. Kaushik, Lokesh Chandra Mishra et al. (6 authors)
Frontiers in Genetics Open Access
Published: Mar 2023
11 citations
447 days after retraction
Exosomal miRNAs as Next-generation Therapy Vehicles in Breast Cancer
Priyanka Thakur, Harshita Dahiya, Ankur Kaushal et al. (6 authors)
Current Gene Therapy
Published: Feb 2023
6 citations
412 days after retraction
A novel PTEN mutant caused by polymorphism in cis-regulatory elements is involved in chemosensitivity in breast cancer.
Jing Wang, Shasha Zhang, Jiaxin Zhang et al. (11 authors)
PubMed
Published: Jan 2023
6 citations
367 days after retraction
Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway
Zhenzhen Wei, Jing Zhou, Hao Yu et al. (8 authors)
Evidence-based Complementary and Alternative Medicine Open Access
Published: Oct 2022
6 citations
281 days after retraction
Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions
Jinxin Tang, Jieyu He, Chengyao Feng et al. (4 authors)
Frontiers in Pharmacology Open Access
Published: May 2022
10 citations
124 days after retraction
Exosomal-microRNA transcriptome profiling of Parental and CSC-like MDA-MB-231 cells in response to cisplatin treatment
May Zie Koh, Wan Yong Ho, Swee Keong Yeap et al. (7 authors)
Pathology - Research and Practice
Published: Mar 2022
9 citations
86 days after retraction
Liquid biopsy-based exo-oncomiRNAs can predict prostate cancer aggressiveness
Manuel A. Santiago, X. Ruiz Plazas, A. Altuna Coy et al. (5 authors)
European Urology Open Access
Published: Feb 2022
33 days after retraction
miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling
Hu Han, Yan Li, Qin Wan et al. (7 authors)
Cancer Cell International Open Access
Published: Jan 2022
16 citations
29 days after retraction
miR-455-5p enhances 5-fluorouracil sensitivity in colorectal cancer cells by targeting PIK3R1 and DEPDC1
Tingting Lou, Luqing Zhang, Zongshan Jin et al. (6 authors)
Open Medicine Open Access
Published: Jan 2022
10 citations
2 days after retraction
The Advancing Roles of Exosomes in Breast Cancer
Xi Wang, Chunxiao Sun, Xiang Huang et al. (7 authors)
Frontiers in Cell and Developmental Biology Open Access
Published: Nov 2021
27 citations
59 days before retraction
Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer
Yi Yi, Min Wu, Hong Zeng et al. (10 authors)
Frontiers in Oncology Open Access
Published: Oct 2021
42 citations
80 days before retraction
A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors
Maria Sromek, Grzegorz Rymkiewicz, Agnieszka Paziewska et al. (12 authors)
Biomolecules Open Access
Published: Sep 2021
8 citations
100 days before retraction
MicroRNAs as a clue to overcome breast cancer treatment resistance
Iris Garrido‐Cano, Birlipta Pattanayak, Anna Adam‐Artigues et al. (8 authors)
Cancer and Metastasis Reviews Open Access
Published: Sep 2021
22 citations
106 days before retraction
miR‐92a promotes cervical cancer cell proliferation, invasion, and migration by directly targeting <i>PIK3R1</i>
Yijun Wang, Aner Chen, Chenyang Zheng et al. (4 authors)
Journal of Clinical Laboratory Analysis Open Access
Published: Jul 2021
20 citations
180 days before retraction
Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
Mohammad Hasan Soheilifar, Nastaran Masoudi-Khoram, Soheil Madadi et al. (8 authors)
Journal of Advanced Research Open Access
Published: Jun 2021
20 citations
187 days before retraction
MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis
Adriana Fodor, Andrada-Luciana Lazăr, Cristina Buchman et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Jun 2021
15 citations
200 days before retraction
Breast Cancer Microenvironment Cross Talk through Extracellular Vesicle RNAs
Samrita Dogra, Bethany N. Hannafon
American Journal Of Pathology
Published: Apr 2021
9 citations
252 days before retraction
Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives
Li-Bo Tang, Shu-Xin Ma, Zhuohui Chen et al. (8 authors)
Biology Open Access
Published: Apr 2021
9 citations
267 days before retraction
MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo
Liwei Ni, Jianhao Xu, Fenglun Zhao et al. (10 authors)
European Journal of Pharmacology Open Access
Published: Mar 2021
22 citations
282 days before retraction
Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer
Seung Wan Son, Mun Gyu Song, Ba Da Yun et al. (4 authors)
Biomedicines Open Access
Published: Mar 2021
7 citations
298 days before retraction
Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
Xavier Ruiz-Plazas, Antonio Altuna-Coy, Marta Alves-Santiago et al. (8 authors)
Cancers Open Access
Published: Jan 2021
27 citations
353 days before retraction
Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment
Chen Han, Cong Zhang, Hengxiao Wang et al. (4 authors)
OncoImmunology Open Access
Published: Jan 2021
76 citations
363 days before retraction
&lt;p&gt;The Role of Exosomes in the Female Reproductive System and Breast Cancers&lt;/p&gt;
Yuqi Bai, Jie Guo, Zhongshan Liu et al. (6 authors)
OncoTargets and Therapy Open Access
Published: Dec 2020
11 citations
394 days before retraction
Epigenetic regulation of resistance to treatments in triple negative and HER2+ breast cancer: miRNAs involved
Paula Cabello Navarro
Unknown Journal Open Access
Published: Sep 2020
458 days before retraction
Exosome-Derived LncRNAs in Lung Cancer
Tao Fan, Nan Sun, Jie He
Frontiers in Oncology Open Access
Published: Sep 2020
35 citations
463 days before retraction
Quick Stats
Total Citations: 31
Years Since Retraction: 3.9 years
Open Access: Yes
Last Checked: Jul 24, 2025